Literature DB >> 629662

Recurrent disseminated vasculomyelinopathy.

C M Poser, G Román, E S Emery.   

Abstract

The monosymptomatic (recurrent infantile hemiplegia) and the polysymptomatic forms of disseminated vasculomyelinopathy that follow various infections and antigenic challenge to the nervous system were seen in two cases. These cases emphasize the importance of vasculopathy as the initial and obligatory component of the postinfectious and postimmunization neurologic syndromes as well as the clinical and pathological variability of the secondary effects on the nervous system. Recurrent infantile hemiplegia occurred in the first patient. In the second patient, after two episodes of postinfectious myelinoclastic encephalopathy, concurrent acute hemorrhagic leukoencephalopathy and an acute Guillain-Barré syndrome following swine flu vaccination developed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629662     DOI: 10.1001/archneur.1978.00500270048010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Serial cerebral CT abnormalities in relapsing acute disseminated encephalomyelitis.

Authors:  R W Walker; J Gawler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

2.  The pathology and pathogenesis of tuberculous encephalopathy and myeloradiculopathy: a comparison with allergic encephalomyelitis.

Authors:  D K Dastur
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

Review 3.  Multiple sclerosis.

Authors:  C M Poser
Journal:  Med Clin North Am       Date:  1979-07       Impact factor: 5.456

4.  Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia.

Authors:  S Khan; B A Yaqub; C M Poser; S M al Deeb; S Bohlega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

5.  Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).

Authors:  Gustavo C Román; Fernando Gracia; Antonio Torres; Alexis Palacios; Karla Gracia; Diógenes Harris
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.